Resultados de procura - David D. Thompson
- Mostrando 1 - 20 Resultados de 21
- Go to Next Page
-
1
-
2
-
3
-
4
Prostaglandin E2 receptors in bone formation por M. Li, David D. Thompson, Vishwas Paralkar
Publicado 2007Revisão -
5
-
6
-
7
-
8
-
9
Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Sca... por Michael P. Whyte, Kenji P. Fujita, Scott Moseley, David D. Thompson, William H. McAlister
Publicado 2018Artigo -
10
Lasofoxifene (CP-336,156), a Selective Estrogen Receptor Modulator, Prevents Bone Loss Induced by Aging and Orchidectomy in the Adult Rat por Hua Zhu Ke, Hong Qi, David T. Crawford, Kristin L. Chidsey-Frink, Hollis A. Simmons, David D. Thompson
Publicado 2000Artigo -
11
-
12
-
13
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia por Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono, Richard J. Riese, Scott Moseley, Agustin Melian, David D. Thompson, Nicholas Bishop, Christine Hofmann
Publicado 2015Artigo -
14
Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family por Vishwas Paralkar, Amy L. Vail, W A Grasser, Thomas A. Brown, Hong Xu, Slobodan Vukičević, Hua Zhu Ke, Hong Qi, Thomas A. Owen, David D. Thompson
Publicado 1998Artigo -
15
The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons por David D. Thompson, J.G. Seedor, H. Quartuccio, Howard F. Solomon, Christine Fioravanti, James S. Davidson, Hilton J. Klein, Rod Jackson, J. Clair, D. Frankenfield, E. Brown, Hollis A. Simmons, Gideon A. Rodan
Publicado 1992Artigo -
16
Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption por Hua Zhu Ke, Hong Qi, A. Frederik Weidema, Qing Zhang, Nattapon Panupinthu, David T. Crawford, W A Grasser, Vishwas Paralkar, Mei Li, Laurent Audoly, Christopher A. Gabel, W.S.S. Jee, S. Jeffrey Dixon, Stephen M. Sims, David D. Thompson
Publicado 2003Artigo -
17
Asfotase alfa therapy for children with hypophosphatasia por Michael P. Whyte, Katherine L. Madson, Dawn Phillips, Amy Reeves, William H. McAlister, Amy Yakimoski, Karen Mack, Kim Hamilton, K. G. Kagan, Kenji P. Fujita, David D. Thompson, Scott Moseley, Tatjana Odrljin, Cheryl R. Greenberg
Publicado 2016Artigo -
18
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women por Andrea Z. LaCroix, TJ Powles, C. Kent Osborne, K. Wolter, John R. Thompson, David D. Thompson, D. Craig Allred, Roy A. Armstrong, S. R. Cummings, Richard Eastell, Kristine E. Ensrud, PE Goss, Andrew Lee, P. Neven, David M. Reid, Madelyn Curto, Slobodan Vukičević
Publicado 2010Artigo -
19
Lasofoxifene in Postmenopausal Women with Osteoporosis por Steven R. Cummings, Kristine E. Ensrud, Pierre D. Delmas, Andrea Z. LaCroix, Slobodan Vukičević, David M. Reid, Steven R. Goldstein, Usha Sriram, Andy Lee, John R. Thompson, Róisín Armstrong, David D. Thompson, Trevor J. Powles, José Zanchetta, David L. Kendler, Patrick Neven, Richard Eastell
Publicado 2010Artigo -
20
Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models por Hua Zhu Ke, Vishwas Paralkar, W A Grasser, David T. Crawford, Hong Qi, Hollis A. Simmons, C.M. Pirie, Kristin L. Chidsey-Frink, Thomas A. Owen, Steven L. Smock, Hong Ka Chen, W.S.S. Jee, Kimberly O. Cameron, Robert L. Rosati, Thomas A. Brown, Paul DaSilva‐Jardine, David D. Thompson
Publicado 1998Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Chemistry
Endocrinology
Biochemistry
Osteoporosis
Bone remodeling
Bone resorption
Enzyme
Alkaline phosphatase
Breast cancer
Calcium
Cancer
Biology
Bone density
Estrogen
Ovariectomized rat
Parathyroid hormone
Receptor
Bisphosphonate
Cell biology
Diphosphonates
Estrogen receptor
Hypophosphatasia
Kidney
Osteoclast
Phosphate
Surgery
Agonist
Alendronic acid